Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | +4.17% | -0.40% | +6.84% |
May. 13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
May. 09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.84% | 93.41M | |
+18.34% | 124B | |
+15.06% | 109B | |
-6.39% | 23.84B | |
+2.39% | 22.42B | |
-12.11% | 17.5B | |
-41.64% | 16.43B | |
-12.07% | 16.61B | |
+1.05% | 13.4B | |
+25.87% | 11.47B |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating